Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 4.4% on Analyst Downgrade

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 4.4% during mid-day trading on Wednesday after KeyCorp lowered their price target on the stock from $12.00 to $10.00. KeyCorp currently has an overweight rating on the stock. Recursion Pharmaceuticals traded as low as $7.04 and last traded at $7.16. Approximately 4,653,415 shares traded hands during […]

Leave a Reply

Your email address will not be published.

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 4.4% on Analyst Downgrade

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 4.4% during mid-day trading on Wednesday after KeyCorp lowered their price target on the stock from $12.00 to $10.00. KeyCorp currently has an overweight rating on the stock. Recursion Pharmaceuticals traded as low as $7.04 and last traded at $7.16. Approximately 4,653,415 shares traded hands during […]

Leave a Reply

Your email address will not be published.

Previous post The Procter & Gamble Company (NYSE:PG) Shares Acquired by RMR Wealth Builders
Next post iShares Bitcoin Trust (NASDAQ:IBIT) Trading Down 1.3% – Here’s What Happened